First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative.
作者信息
Azuma Hiroshi, Amano Toraji, Kamiyama Naoya, Takehara Naofumi, Jingu Maki, Takagi Harumi, Sugita Osamu, Kobayashi Naoko, Kure Tomoko, Shimizu Taro, Ishida Tatsuhiro, Matsumoto Masanori, Sakai Hiromi
机构信息
Department of Pediatrics, Asahikawa Medical University, Asahikawa, Japan.
Clinical Research and Medical Innovation Center, Hokkaido University Hospital, Sapporo, Japan.
出版信息
Blood Adv. 2022 Nov 8;6(21):5711-5715. doi: 10.1182/bloodadvances.2022007977.
Abstract
摘要
Zotero 插件